These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 5367857)

  • 1. [Investigation of antithrombogenic properties of modified polymers for use in cardiovascular surgery].
    Vasiukov SE; Karpinskaia VM; Kolesnikov GS; Novikova SP; Smurova EV
    Eksp Khir Anesteziol; 1969; 14(2):51-4. PubMed ID: 5367857
    [No Abstract]   [Full Text] [Related]  

  • 2. [Heparinization of non-biological surfaces. Review of the different processes].
    Guidoin RG; Bergeron P; Awad JA
    Union Med Can; 1974 Jan; 103(1):71-8. PubMed ID: 4811352
    [No Abstract]   [Full Text] [Related]  

  • 3. The approach of thromboelastography in the monitoring of new synthetic antithrombotic agents, GL-522 and GL-2021.
    Iqbal O; Jeske W; Hoppensteadt D; Walenga JM; Fareed J
    Semin Thromb Hemost; 1995; 21 Suppl 4():72-5. PubMed ID: 8747692
    [No Abstract]   [Full Text] [Related]  

  • 4. [Better understanding of blood coagulation in vivo].
    Löwenberg EC; Dielis AW; Meijers JC; ten Cate H; Levi M
    Ned Tijdschr Geneeskd; 2009 Jan; 153(1-2):30-7. PubMed ID: 19198210
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fibrinolytic action of Complamin (R). Preliminary report].
    Harel P; Gauthier J
    Union Med Can; 1966 May; 95(5):542-5. PubMed ID: 5932651
    [No Abstract]   [Full Text] [Related]  

  • 6. The relationship between wine consumption and cardiovascular risk: from epidemiological evidence to biological plausibility.
    Rotondo S; Di Castelnuovo A; de Gaetano G
    Ital Heart J; 2001 Jan; 2(1):1-8. PubMed ID: 11214695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new antithrombogenic material with long polyethyleneoxide chains.
    Mori Y; Nagaoka S; Takiuchi H; Kikuchi T; Noguchi N; Tanzawa H; Noishiki Y
    Trans Am Soc Artif Intern Organs; 1982; 28():459-63. PubMed ID: 7164281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulation inhibitors from blood-sucking animals. A new line of developing antithrombotic drugs.
    Markwardt F
    Pharmazie; 1994 May; 49(5):313-6. PubMed ID: 8016176
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anticoagulating properties of fungal proteases tricholysine (triase) and longolytin].
    Serebriakova TN; Andreenko GV; Maksimova RA; Tsymanovich ST; Murashova NL
    Vopr Med Khim; 1984; 30(5):37-40. PubMed ID: 6396943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Athrombogenic substances derived by immobilization of trypsin on the surface of synthetic polymers].
    Salganik RI; Kogan AS; Gonchar AM; Semenova LA; Zemtsova LV
    Vopr Med Khim; 1982; 28(1):113-5. PubMed ID: 7064374
    [No Abstract]   [Full Text] [Related]  

  • 11. Observations on the lysis of artificial thrombi by urokinase.
    Ogston CM; Ogston D; Fullerton HW
    Thromb Diath Haemorrh; 1968 Mar; 19(1):107-16. PubMed ID: 5690026
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative studies on the effect of urokinase and streptokinase in animal research].
    Hiemeyer V; Rasche H
    Thromb Diath Haemorrh; 1967 Feb; 17(1-2):58-64. PubMed ID: 5584960
    [No Abstract]   [Full Text] [Related]  

  • 13. Factor Xa inhibitors: today and beyond.
    Walenga JM; Jeske WP; Hoppensteadt D; Fareed J
    Curr Opin Investig Drugs; 2003 Mar; 4(3):272-81. PubMed ID: 12735228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies with a preparation of urokinase.
    Dubber AH; McNicol GP; Wilson PA; Douglas AS
    Thromb Diath Haemorrh; 1967 Aug; 18(1-2):133-49. PubMed ID: 6066598
    [No Abstract]   [Full Text] [Related]  

  • 15. [Heparin in surgery and artificial circulation: pro and contra. Is there an alternative?].
    Roĭtman EV; Dement'eva II; Meshcheriakov AV
    Anesteziol Reanimatol; 1997; (6):65-9. PubMed ID: 9511253
    [No Abstract]   [Full Text] [Related]  

  • 16. [The antithrombotic and thrombolytic activity of tuftsin].
    Liapina LA; Pastorova VE; Kondashevskaia MV; Kudriashov BA; Kalikhevich VN; Kamenskiĭ AA; Ashmarin IP
    Biull Eksp Biol Med; 1993 Nov; 116(11):451-2. PubMed ID: 8312523
    [No Abstract]   [Full Text] [Related]  

  • 17. [Fibrinolytic therapy of arteriosclerosis. Influence on hemocoagulation of a total arterial wall extract for oral use].
    Guglielmi G; Barlattani M; Garbagnati N; Iaschi P; Ciavarelli F
    Clin Ter; 1969 Sep; 50(6):527-36. PubMed ID: 5406050
    [No Abstract]   [Full Text] [Related]  

  • 18. Reperfusion and antithrombotic strategies for acute MI.
    Belli G; Topol EJ
    Contemp Intern Med; 1995 Jul; 7(7):31-8, 43-5. PubMed ID: 10150611
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative efficacy of tiklid and aspirin in patients with unstable angina].
    Rebrov AP; Voskoboĭ IV
    Ter Arkh; 2001; 73(12):25-9. PubMed ID: 11858103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Heparins, antivitamins K. Principles and rules of use. Posology of non-fractionated heparins].
    Delsart D; Chambefort V; Decousus H
    Rev Prat; 2001 Sep; 51(13):1489-97. PubMed ID: 11601082
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.